Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist

por Shram, Megan J., Silverman, Bernard, Ehrich, Elliot, Sellers, Edward M., Turncliff, Ryan
Publicado 2015

Evaluation of Opioid Modulation in Major Depressive Disorder

por Ehrich, Elliot, Turncliff, Ryan, Du, Yangchun, Leigh-Pemberton, Richard, Fernandez, Emilio, Jones, Reese, Fava, Maurizio
Publicado 2015

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches

por Peciña, Marta, Karp, Jordan F., Mathew, Sanjay, Todtenkopf, Mark S., Ehrich, Elliot W., Zubieta, Jon-Kar
Publicado 2018

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies

por Fava, Maurizio, Thase, Michael E., Trivedi, Madhukar H., Ehrich, Elliot, Martin, William F., Memisoglu, Asli, Nangia, Narinder, Stanford, Arielle D., Yu, Miao, Pathak, Sanjeev
Publicado 2018